Skip to main content
. 2016 Feb 2;12(4):922–930. doi: 10.1080/21645515.2015.1115934

Figure 2.

Figure 2.

Comparison of the 2 safety sets in the vaccine group or in the placebo group. The rate of adverse reactions in the first safety analysis population was compared to the rate of adverse reactions in the second safety analysis population in the vaccine group (A) and placebo group (B).